GCT vs NVDA

GCT presents a compelling value proposition with a Piotroski F-Score of 4/9 indicating stable financial health and a current price ($46.50) significantly below its growth-based intrinsic value of $107.97. The company exhibits exceptional profitability with an ROE of 30.84% and a very low P/E ratio of 12.70 relative to the technology sector average. However, this fundamental strength is heavily countered by aggressive insider selling and a bearish technical trend. The massive earnings surprise track record suggests the market may still be underestimating the company's growth trajectory.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.